189 related articles for article (PubMed ID: 19883596)
1. Solution and crystal molecular dynamics simulation study of m4-cyanovirin-N mutants complexed with di-mannose.
Vorontsov II; Miyashita O
Biophys J; 2009 Nov; 97(9):2532-40. PubMed ID: 19883596
[TBL] [Abstract][Full Text] [Related]
2. Crystal molecular dynamics simulations to speed up MM/PB(GB)SA evaluation of binding free energies of di-mannose deoxy analogs with P51G-m4-Cyanovirin-N.
Vorontsov II; Miyashita O
J Comput Chem; 2011 Apr; 32(6):1043-53. PubMed ID: 20949512
[TBL] [Abstract][Full Text] [Related]
3. Computational study of the dynamics of mannose disaccharides free in solution and bound to the potent anti-HIV virucidal protein cyanovirin.
Margulis CJ
J Phys Chem B; 2005 Mar; 109(8):3639-47. PubMed ID: 16851402
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.
Chang LC; Bewley CA
J Mol Biol; 2002 Apr; 318(1):1-8. PubMed ID: 12054763
[TBL] [Abstract][Full Text] [Related]
5. The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120.
Bewley CA; Otero-Quintero S
J Am Chem Soc; 2001 May; 123(17):3892-902. PubMed ID: 11457139
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120.
Bewley CA
Structure; 2001 Oct; 9(10):931-40. PubMed ID: 11591348
[TBL] [Abstract][Full Text] [Related]
7. The role of Glu41 in the binding of dimannose to P51G-m4-CVN.
Ramadugu SK; Li Z; Kashyap HK; Margulis CJ
Biochemistry; 2014 Mar; 53(9):1477-84. PubMed ID: 24524298
[TBL] [Abstract][Full Text] [Related]
8. A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity.
Fromme R; Katiliene Z; Giomarelli B; Bogani F; Mc Mahon J; Mori T; Fromme P; Ghirlanda G
Biochemistry; 2007 Aug; 46(32):9199-207. PubMed ID: 17636873
[TBL] [Abstract][Full Text] [Related]
9. Multivalent interactions with gp120 are required for the anti-HIV activity of Cyanovirin.
Liu Y; Carroll JR; Holt LA; McMahon J; Giomarelli B; Ghirlanda G
Biopolymers; 2009; 92(3):194-200. PubMed ID: 19235857
[TBL] [Abstract][Full Text] [Related]
10. A flexible docking scheme efficiently captures the energetics of glycan-cyanovirin binding.
Bolia A; Woodrum BW; Cereda A; Ruben MA; Wang X; Ozkan SB; Ghirlanda G
Biophys J; 2014 Mar; 106(5):1142-51. PubMed ID: 24606938
[TBL] [Abstract][Full Text] [Related]
11. Conformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 A resolution.
Fromme R; Katiliene Z; Fromme P; Ghirlanda G
Protein Sci; 2008 May; 17(5):939-44. PubMed ID: 18436959
[TBL] [Abstract][Full Text] [Related]
12. Solution and crystal structures of a sugar binding site mutant of cyanovirin-N: no evidence of domain swapping.
Matei E; Furey W; Gronenborn AM
Structure; 2008 Aug; 16(8):1183-94. PubMed ID: 18682220
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the monovalent lectin microvirin in complex with Man(alpha)(1-2)Man provides a basis for anti-HIV activity with low toxicity.
Shahzad-ul-Hussan S; Gustchina E; Ghirlando R; Clore GM; Bewley CA
J Biol Chem; 2011 Jun; 286(23):20788-96. PubMed ID: 21471192
[TBL] [Abstract][Full Text] [Related]
14. Site-specific discrimination by cyanovirin-N for alpha-linked trisaccharides comprising the three arms of Man(8) and Man(9).
Bewley CA; Kiyonaka S; Hamachi I
J Mol Biol; 2002 Sep; 322(4):881-9. PubMed ID: 12270721
[TBL] [Abstract][Full Text] [Related]
15. Computational models explain the oligosaccharide specificity of cyanovirin-N.
Fujimoto YK; Terbush RN; Patsalo V; Green DF
Protein Sci; 2008 Nov; 17(11):2008-14. PubMed ID: 18809850
[TBL] [Abstract][Full Text] [Related]
16. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
[TBL] [Abstract][Full Text] [Related]
17. Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides.
Botos I; O'Keefe BR; Shenoy SR; Cartner LK; Ratner DM; Seeberger PH; Boyd MR; Wlodawer A
J Biol Chem; 2002 Sep; 277(37):34336-42. PubMed ID: 12110688
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of the HIV-1 inhibitory cyanobacterial protein MVL free and bound to Man3GlcNAc2: structural basis for specificity and high-affinity binding to the core pentasaccharide from n-linked oligomannoside.
Williams DC; Lee JY; Cai M; Bewley CA; Clore GM
J Biol Chem; 2005 Aug; 280(32):29269-76. PubMed ID: 15937331
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of a circular-permuted variant of the potent HIV-inactivating protein cyanovirin-N: structural basis for protein stability and oligosaccharide interaction.
Barrientos LG; Louis JM; Ratner DM; Seeberger PH; Gronenborn AM
J Mol Biol; 2003 Jan; 325(1):211-23. PubMed ID: 12473463
[TBL] [Abstract][Full Text] [Related]
20. Rational and computational design of stabilized variants of cyanovirin-N that retain affinity and specificity for glycan ligands.
Patsalo V; Raleigh DP; Green DF
Biochemistry; 2011 Dec; 50(49):10698-712. PubMed ID: 22032696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
